bluebird bio (NASDAQ: BLUE) reported Q1 EPS of ($3.64), versus ($2.99) reported last year. Revenue for the quarter came in at $21.9 million, versus $12.5 million reported last year.

For earnings history and earnings-related data on bluebird bio (BLUE) click here.